Amalgamated Bank Omega Therapeutics, Inc. Transaction History

Amalgamated Bank

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 23, 2024	SELL	$2.73 - $5.32 $7,174 - $13,980	-2,628 Reduced 76.17%	822 $3,000
Q4 2023 Feb 06, 2024	SELL	$1.35 - $3.21 $329 - $783	-244 Reduced 6.61%	3,450 $10,000
Q2 2023 Aug 11, 2023	BUY	$5.6 - $9.66 $20,686 - $35,684	3,694 New	3,694 $20,000
Q2 2022 Aug 15, 2022	SELL	$2.01 - $7.19 $5,991 - $21,433	-2,981 Closed	0 $0
Q1 2022 Jun 30, 2022	BUY	$6.24 - $14.04 $18,601 - $41,853	2,981 New	2,981 $19,000

43.4M

25.8K

Ticker OMGA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 47,853,400
Market Cap $35.9M
Description
Omega Therapeutics, Inc. operates as a development-stage biopharmaceutical company. Its OMEGA Epigenomic Programming platform is designed to coopt nature's operating system by harnessing the power of epigenetics, the mechanism for gene control and cell differentiation. The company is developing omega epigenomic controller (OEC) candidates to up-...

Get notified when there are updates to the investment portfolio of Amalgamated Bank, based on Form 13F filings with the SEC.

Stay updated on Amalgamated Bank with notifications on news.